Tag: Arthritis: Rheumatoid
Serum Biomarkers Can Differentiate Psoriatic Arthritis, RA
Panel of serum protein biomarkers identified and evaluated for potential use in diagnostic testing for early-onset psoriatic arthritis
Intermetatarsal Bursitis ID’d in Clinically Suspect Arthralgia
IMB for 23 percent with CSA; patients with IMB also have increased likelihood of subclinical synovitis, tenosynovitis
ACR: COVID-19 Vaccine Not Tied to Severe Rheumatic Disease Flares
Seropositivity lags after vaccination in those with rheumatic diseases but improves after second dose
ACR: Cycling JAK Inhibitors Feasible for Difficult-to-Treat RA
One-year outcomes similar for cycling JAK inhibitors versus switching to a biologic drug
Impact of Dietary Interventions Inconsistent in Rheumatoid Arthritis
Dietary interventions combined with omega-3 supplementation may provide additional benefit
Pain, Fatigue in Rheumatoid Arthritis Tied to Sitting, Standing Time
Longitudinal and bidirectional associations seen for pain and fatigue with more sedentary time, less standing time
FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
Cyltezo is first interchangeable monoclonal antibody for RA, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, chronic plaque psoriasis
Women With Rheumatoid Arthritis Have Bone Fragility
Findings seen for premenopausal women with systemic fragility at peripheral sites versus matched controls without rheumatoid arthritis
Gene Variant Tied to Risk for Interstitial Lung Disease in RA
For patients with rheumatoid arthritis, lifetime risks for ILD were 16.8 percent for MUC5B carriers, 6.1 percent for noncarriers
